Stock comparison
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.25 B vs $167.41 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.25 B vs $167.41 B).
Market value leader
AMGN
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.25 B vs $167.41 B).
Revenue leader
AMGN
GILD: $29.44B vs AMGN: $36.75B.
Profit leader
GILD
GILD: $8.51B vs AMGN: $7.71B.
Margin leader
GILD
GILD: 28.9% vs AMGN: 21.0% net margin.
| Metric | GILD | AMGN |
|---|---|---|
| Market cap | $167.41 B | $196.25 B |
| US-listed rank | #92 | #77 |
| Revenue (latest FY) | $29.44B | $36.75B |
| Net income (latest FY) | $8.51B | $7.71B |
| Net margin | 28.9% | 21.0% |
| P/E (trailing FY) | 19.7x | 25.5x |
| SEC filings | 968 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 1.2x more valuable than GILEAD SCIENCES, INC. by market capitalization ($196.25 B vs $167.41 B).
In their latest fiscal years, GILEAD SCIENCES, INC. reported $29.44B in revenue while AMGEN INC reported $36.75B.
Full pages: GILEAD SCIENCES, INC. and AMGEN INC, or browse the full rankings.